Department of Pharmacy, Institute of Chemical and Pharmaceutical Sciences, Kohat University of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan.
Department of Zoology, Kohat University of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan.
PLoS Negl Trop Dis. 2021 Mar 3;15(3):e0009099. doi: 10.1371/journal.pntd.0009099. eCollection 2021 Mar.
Cutaneous leishmaniasis has been endemic since decades. Millions of cases are reported worldwide specially in developing and underdeveloped countries. There are 2 major types of cutaneous leishmaniasis based on the causating species found in different regions of the world. These include New and Old World cutaneous leishmaniasis, which are self-healing, but if not treated, these may cause severe scars and many other complications like mucosal involvement. The conventional gold standard treatment for both types is mainly intralesional or parenteral administration of antimonial. Lately, a great deal of research has been done on development of topical treatment based on single agent or combination therapy. This review summarizes the current state of literature regarding therapeutic outcome of topical treatment against cutaneous leishmaniasis caused by different species in different regions.
皮肤利什曼病数十年来一直呈地方性流行。全世界报告了数百万例病例，特别是在发展中国家和不发达国家。根据世界不同地区发现的致病物种，有 2 种主要类型的皮肤利什曼病。这些包括新和旧世界皮肤利什曼病，它们是可以自行愈合的，但如果不治疗，这些疾病可能会导致严重的疤痕和许多其他并发症，如黏膜受累。这两种类型的传统金标准治疗主要是局部或静脉内给予锑剂。最近，人们对基于单一药物或联合疗法的局部治疗的开发进行了大量研究。这篇综述总结了有关不同地区不同物种引起的皮肤利什曼病的局部治疗疗效的文献现状。
